Literature DB >> 14745585

Genetic and environmental factors in the pathogenesis of Huntington's disease.

Anton van Dellen1, Anthony J Hannan.   

Abstract

Huntington's disease is a fatal inherited disorder in which there is progressive neurodegeneration in specific brain areas, mainly the striatum and cerebral cortex, producing motor, cognitive, and psychiatric symptoms. The trinucleotide repeat mutation involved is common to many other brain diseases, which may therefore involve similar mechanisms of pathogenesis. We are beginning to understand how a CAG trinucleotide repeat expansion in the disease gene, encoding an expanded polyglutamine tract, induces neuronal dysfunction and symptomatology in Huntington's disease. Recent evidence that environmental factors modify the onset and progression of neurodegeneration has shed new light on Huntington's disease and other devastating brain diseases. This review focuses on genetic mediators, environmental modulators, and associated gene-environment interactions in the pathogenesis of Huntington's disease.

Entities:  

Mesh:

Year:  2004        PMID: 14745585     DOI: 10.1007/s10048-003-0169-5

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  72 in total

1.  Effects of environmental enrichment on gene expression in the brain.

Authors:  C Rampon; C H Jiang; H Dong; Y P Tang; D J Lockhart; P G Schultz; J Z Tsien; Y Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.

Authors:  D Martindale; A Hackam; A Wieczorek; L Ellerby; C Wellington; K McCutcheon; R Singaraja; P Kazemi-Esfarjani; R Devon; S U Kim; D E Bredesen; F Tufaro; M R Hayden
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.

Authors:  Paul J Muchowski; Ke Ning; Crislyn D'Souza-Schorey; Stanley Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  Evidence for the GluR6 gene associated with younger onset age of Huntington's disease.

Authors:  M E MacDonald; J P Vonsattel; J Shrinidhi; N N Couropmitree; L A Cupples; E D Bird; J F Gusella; R H Myers
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

7.  Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.

Authors:  L Mangiarini; K Sathasivam; A Mahal; R Mott; M Seller; G P Bates
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

8.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

9.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

10.  Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid.

Authors:  Alpaslan Dedeoglu; Robert J Ferrante; Ole A Andreassen; Wolfgang H Dillmann; M Flint Beal
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

View more
  11 in total

1.  A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study.

Authors:  H Diana Rosas; Martin Reuter; Gheorghe Doros; Stephanie Y Lee; Tyler Triggs; Keith Malarick; Bruce Fischl; David H Salat; Steven M Hersch
Journal:  Mov Disord       Date:  2011-05-24       Impact factor: 10.338

Review 2.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

Review 3.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Huntington's disease in the United States: Variation by demographic and socioeconomic factors.

Authors:  Emilie Bruzelius; Joseph Scarpa; Yiyi Zhao; Sanjay Basu; James H Faghmous; Aaron Baum
Journal:  Mov Disord       Date:  2019-03-13       Impact factor: 10.338

5.  Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Authors:  Sophie Tezenas du Montcel; Alexandra Durr; Peter Bauer; Karla P Figueroa; Yaeko Ichikawa; Alessandro Brussino; Sylvie Forlani; Maria Rakowicz; Ludger Schöls; Caterina Mariotti; Bart P C van de Warrenburg; Laura Orsi; Paola Giunti; Alessandro Filla; Sandra Szymanski; Thomas Klockgether; José Berciano; Massimo Pandolfo; Sylvia Boesch; Bela Melegh; Dagmar Timmann; Paola Mandich; Agnès Camuzat; Jun Goto; Tetsuo Ashizawa; Cécile Cazeneuve; Shoji Tsuji; Stefan-M Pulst; Alfredo Brusco; Olaf Riess; Alexis Brice; Giovanni Stevanin
Journal:  Brain       Date:  2014-06-26       Impact factor: 13.501

6.  Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism.

Authors:  Jennifer L Madison; Michal Wegrzynowicz; Michael Aschner; Aaron B Bowman
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

7.  Analysis of the GGGGCC Repeat Expansions of the C9orf72 Gene in SCA3/MJD Patients from China.

Authors:  Chunrong Wang; Zhao Chen; Fang Yang; Bin Jiao; Huirong Peng; Yuting Shi; Yaqin Wang; Fengzhen Huang; Junling Wang; Lu Shen; Kun Xia; Beisha Tang; Tetsuo Ashizawa; Hong Jiang
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

8.  Glycation potentiates neurodegeneration in models of Huntington's disease.

Authors:  Hugo Vicente Miranda; Marcos António Gomes; Joana Branco-Santos; Carlo Breda; Diana F Lázaro; Luísa Vaqueiro Lopes; Federico Herrera; Flaviano Giorgini; Tiago Fleming Outeiro
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

9.  Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.

Authors:  Luisa Massai; Lara Petricca; Letizia Magnoni; Luca Rovetini; Salman Haider; Ralph Andre; Sarah J Tabrizi; Sigurd D Süssmuth; Bernhard G Landwehrmeyer; Andrea Caricasole; Giuseppe Pollio; Simonetta Bernocco
Journal:  BMC Biochem       Date:  2013-11-25       Impact factor: 4.059

10.  Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases.

Authors:  Manikandan Narayanan; Jimmy L Huynh; Kai Wang; Xia Yang; Seungyeul Yoo; Joshua McElwee; Bin Zhang; Chunsheng Zhang; John R Lamb; Tao Xie; Christine Suver; Cliona Molony; Stacey Melquist; Andrew D Johnson; Guoping Fan; David J Stone; Eric E Schadt; Patrizia Casaccia; Valur Emilsson; Jun Zhu
Journal:  Mol Syst Biol       Date:  2014-07-30       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.